727 related articles for article (PubMed ID: 27785881)
1. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
Kodama A; Yamamoto M; Shimura T; Kagase A; Koyama Y; Tada N; Takagi K; Araki M; Yamanaka F; Shirai S; Watanabe Y; Hayashida K
Catheter Cardiovasc Interv; 2017 Sep; 90(3):E55-E62. PubMed ID: 27785881
[TBL] [Abstract][Full Text] [Related]
2. Simple, effective and safe vascular access site closure with the double-ProGlide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation.
Griese DP; Reents W; Diegeler A; Kerber S; Babin-Ebell J
Catheter Cardiovasc Interv; 2013 Nov; 82(5):E734-41. PubMed ID: 23765732
[TBL] [Abstract][Full Text] [Related]
3. Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure.
Saleh N; De Palma R; Settergren M; Rück A
Catheter Cardiovasc Interv; 2015 Dec; 86(7):1255-61. PubMed ID: 26332528
[TBL] [Abstract][Full Text] [Related]
4. Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation.
Barbanti M; Capranzano P; Ohno Y; Gulino S; Sgroi C; Immè S; Tamburino C; Cannata S; Patanè M; Di Stefano D; Todaro D; Di Simone E; Deste W; Gargiulo G; Capodanno D; Grasso C; Tamburino C
EuroIntervention; 2015 Oct; 11(6):690-7. PubMed ID: 26499222
[TBL] [Abstract][Full Text] [Related]
5. The utilization of single versus double Perclose devices for transfemoral aortic valve replacement access site closure: Insights from Cleveland Clinic Aortic Valve Center.
Bazarbashi N; Ahuja K; Gad MM; Sammour YM; Kaur M; Karrthik A; Saad AM; Khubber S; Dhaliwal K; Mick SL; Navia JL; Puri R; Reed GW; Krishnaswamy A; Kapadia SR
Catheter Cardiovasc Interv; 2020 Aug; 96(2):442-447. PubMed ID: 31713996
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of hybrid vascular closure technique using both a suture- and collagen-mediated closure device after transfemoral transcatheter aortic valve implantation.
Al-Ani A; Hoffmann P; von Lueder T; Opdahl A
Catheter Cardiovasc Interv; 2020 May; 95(6):1171-1175. PubMed ID: 31379116
[TBL] [Abstract][Full Text] [Related]
7. Impact of suture mediated femoral access site closure with the Prostar XL compared to the ProGlide system on outcome in transfemoral aortic valve implantation.
Seeger J; Gonska B; Rodewald C; Rottbauer W; Wöhrle J
Int J Cardiol; 2016 Nov; 223():564-567. PubMed ID: 27561160
[TBL] [Abstract][Full Text] [Related]
8. Impact of percutaneous femoral arteriotomy closure using the MANTA
De Palma R; Settergren M; Rück A; Linder R; Saleh N
Catheter Cardiovasc Interv; 2018 Nov; 92(5):954-961. PubMed ID: 29575678
[TBL] [Abstract][Full Text] [Related]
9. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation.
Lareyre F; Raffort J; Dommerc C; Benhammamia M; Bourlon F; Habib Y; Mialhe C
Vasc Endovascular Surg; 2017 Jul; 51(5):282-287. PubMed ID: 28474978
[TBL] [Abstract][Full Text] [Related]
10. One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation.
Mehilli J; Jochheim D; Abdel-Wahab M; Rizas KD; Theiss H; Spenkuch N; Zadrozny M; Baquet M; El-Mawardy M; Sato T; Lange P; Kuppatt C; Greif M; Hausleiter J; Bauer A; Schwarz F; Pichlmaier M; Hagl C; Richardt G; Massberg S
EuroIntervention; 2016 Nov; 12(10):1298-1304. PubMed ID: 27866140
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Closure Failure following Percutaneous Transfemoral Transcatheter Aortic Valve Implantation.
Lee CH; Ko YG; Park Y; Shim CY; Hong GR; Lee SH; Lee S; Jung HW; Hong SJ; Ahn CM; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
Ann Vasc Surg; 2020 Jul; 66():406-414. PubMed ID: 31918036
[TBL] [Abstract][Full Text] [Related]
12. Single versus double use of a suture-based closure device for transfemoral aortic valve implantation.
Reifart J; Liebetrau C; Weferling M; Dörr O; Renker M; Bhumimuang K; Liakopoulos O; Choi YH; Nef H; Hamm CW; Kim WK
Int J Cardiol; 2021 May; 331():183-188. PubMed ID: 33529662
[TBL] [Abstract][Full Text] [Related]
13. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation.
Barbash IM; Barbanti M; Webb J; Molina-Martin De Nicolas J; Abramowitz Y; Latib A; Nguyen C; Deuschl F; Segev A; Sideris K; Buccheri S; Simonato M; Rosa FD; Tamburino C; Jilaihawi H; Miyazaki T; Himbert D; Schofer N; Guetta V; Bleiziffer S; Tchetche D; Immè S; Makkar RR; Vahanian A; Treede H; Lange R; Colombo A; Dvir D
Eur Heart J; 2015 Dec; 36(47):3370-9. PubMed ID: 26314688
[TBL] [Abstract][Full Text] [Related]
14. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
[TBL] [Abstract][Full Text] [Related]
15. Incidence, Predictors, and Mid-Term Outcomes of Percutaneous Closure Failure After Transfemoral Aortic Valve Implantation Using an Expandable Sheath (from the Optimized Transcatheter Valvular Intervention [OCEAN-TAVI] Registry).
Nara Y; Watanabe Y; Kozuma K; Kataoka A; Nakashima M; Hioki H; Kawashima H; Nagura F; Shirai S; Tada N; Araki M; Naganuma T; Yamanaka F; Yamamoto M; Hayashida K
Am J Cardiol; 2017 Feb; 119(4):611-617. PubMed ID: 27939382
[TBL] [Abstract][Full Text] [Related]
16. The novel echo-guided ProGlide technique during percutaneous transfemoral transcatheter aortic valve implantation.
Honda Y; Araki M; Yamawaki M; Tokuda T; Tsutumi M; Mori S; Sakamoto Y; Kobayashi N; Hirano K; Ito Y
J Interv Cardiol; 2018 Apr; 31(2):216-222. PubMed ID: 29193337
[TBL] [Abstract][Full Text] [Related]
17. Dedicated Closure Device for Transcaval Access Closure: From Concept to First-in-Human Testing.
Rogers T; Greenbaum AB; Babaliaros VC; Stine AM; Khan JM; Schenke WH; Eng MH; Paone G; Leshnower BG; Satler LF; Waksman R; Chen MY; Lederman RJ
JACC Cardiovasc Interv; 2019 Nov; 12(21):2198-2206. PubMed ID: 31629746
[TBL] [Abstract][Full Text] [Related]
18. Impact of routine crossover balloon occlusion technique on access-related vascular complications following transfemoral transcatheter aortic valve replacement.
Zaman S; Gooley R; Cheng V; McCormick L; Meredith IT
Catheter Cardiovasc Interv; 2016 Aug; 88(2):276-84. PubMed ID: 27107395
[TBL] [Abstract][Full Text] [Related]
19. Manta versus Perclose ProGlide vascular closure device after transcatheter aortic valve implantation: Initial experience from a large European center.
Dumpies O; Kitamura M; Majunke N; Hartung P; Haag A; Wilde J; Desch S; Sandri M; Crusius L; Noack T; Kiefer P; Leontyev S; Borger M; Thiele H; Holzhey D; Abdel-Wahab M
Cardiovasc Revasc Med; 2022 Apr; 37():34-40. PubMed ID: 34257057
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of ProGlide Versus Prostar XL Vascular Closure Devices in Transcatheter Aortic Valve Replacement: The RISPEVA Registry.
Berti S; Bedogni F; Giordano A; Petronio AS; Iadanza A; Bartorelli AL; Reimers B; Spaccarotella C; Trani C; Attisano T; Marella Cenname A; Sardella G; Bonmassari R; Medda M; Tomai F; Tarantini G; Navarese EP;
J Am Heart Assoc; 2020 Nov; 9(21):e018042. PubMed ID: 33103545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
